HCW Biologics is trading at $4.03 (up 5.4%), rebounding from recent weakness as sentiment improves across the biotech and growth sectors.
- The move aligns with a broader market risk-on rally, with major indices like the S&P 500 and Nasdaq trending higher.
- With no company-specific news reported, the gain appears driven by a recovery in speculative assets following recent volatility.
- The stock is participating in a sector-wide bounce as investors rotate back into growth-oriented names.